Xcell Therapeutics Inc. (KOSDAQ:373110)
South Korea flag South Korea · Delayed Price · Currency is KRW
3,725.00
+115.00 (3.19%)
Apr 1, 2025, 3:30 PM KST

Xcell Therapeutics Statistics

Total Valuation

KOSDAQ:373110 has a market cap or net worth of KRW 40.75 billion. The enterprise value is 37.65 billion.

Market Cap 40.75B
Enterprise Value 37.65B

Important Dates

The last earnings date was Friday, March 28, 2025.

Earnings Date Mar 28, 2025
Ex-Dividend Date n/a

Share Statistics

KOSDAQ:373110 has 10.94 million shares outstanding. The number of shares has increased by 13.07% in one year.

Current Share Class n/a
Shares Outstanding 10.94M
Shares Change (YoY) +13.07%
Shares Change (QoQ) +1.45%
Owned by Insiders (%) 17.72%
Owned by Institutions (%) 0.08%
Float 7.03M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 19.26
PB Ratio 4.46
P/TBV Ratio 4.75
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -3.94
EV / Sales 19.46
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF -5.10

Financial Position

The company has a current ratio of 2.14, with a Debt / Equity ratio of 0.63.

Current Ratio 2.14
Quick Ratio 1.90
Debt / Equity 0.63
Debt / EBITDA n/a
Debt / FCF -0.77
Interest Coverage -2,119.47

Financial Efficiency

Return on equity (ROE) is -165.90% and return on invested capital (ROIC) is -49.18%.

Return on Equity (ROE) -165.90%
Return on Assets (ROA) -42.63%
Return on Invested Capital (ROIC) -49.18%
Return on Capital Employed (ROCE) -77.86%
Revenue Per Employee n/a
Profits Per Employee n/a
Employee Count 61
Asset Turnover 0.14
Inventory Turnover 4.44

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

Beta (5Y) n/a
52-Week Price Change n/a
50-Day Moving Average 4,378.60
200-Day Moving Average n/a
Relative Strength Index (RSI) 28.26
Average Volume (20 Days) 90,528

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, KOSDAQ:373110 had revenue of KRW 1.93 billion and -9.54 billion in losses. Loss per share was -954.00.

Revenue 1.93B
Gross Profit -1.40B
Operating Income -9.33B
Pretax Income -9.54B
Net Income -9.54B
EBITDA -7.68B
EBIT -9.33B
Loss Per Share -954.00
Full Income Statement

Balance Sheet

The company has 8.80 billion in cash and 5.70 billion in debt, giving a net cash position of 3.10 billion or 283.43 per share.

Cash & Cash Equivalents 8.80B
Total Debt 5.70B
Net Cash 3.10B
Net Cash Per Share 283.43
Equity (Book Value) 9.12B
Book Value Per Share 835.63
Working Capital 5.61B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -7.00 billion and capital expenditures -382.69 million, giving a free cash flow of -7.38 billion.

Operating Cash Flow -7.00B
Capital Expenditures -382.69M
Free Cash Flow -7.38B
FCF Per Share -674.60
Full Cash Flow Statement

Margins

Gross Margin -72.30%
Operating Margin -482.33%
Pretax Margin -493.35%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

KOSDAQ:373110 does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -13.07%
Shareholder Yield -13.07%
Earnings Yield -23.42%
FCF Yield -18.11%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

KOSDAQ:373110 has an Altman Z-Score of -0.94. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -0.94
Piotroski F-Score n/a